Print this page

Can Indian pharma fight back?

Stocks of Indian pharmaceutical companies have taken a knock over the last year and this is reflected in the poor run of the S&P BSE Healthcare Index. While its defensive cousins such as FMCG and information technology indices closed with flat one-year returns, the healthcare index moved in line with the broad-based Sensex and Nifty to close with losses of around 4 per cent.

This poor performance is in sharp contrast to the performance of these stocks between May 2014 and May 2015.

Last modified onSunday, 15 May 2016 22:06
© supplychainreview.com. All Rights Reserved.